$XPO

Landry Allison sold $517K of XPO

Landry Allison sold 2,400 shares of XPO, Inc. (XPO) at $215.61 ($0.52M total) on 2026-05-28.

Original reporting
SEC EDGAR · Landry Allison
Published May 29, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 29, 2026, 8:08 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$XPO
Neutral
medium confidence
Mentioned
$XPO
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$XPONeutralLow
01

Why it matters

The disclosed open-market sale updates insider ownership levels but does not provide new information about company operations, guidance, or strategy.

02

Market read

Primarily a sentiment/positioning datapoint for XPO rather than a catalyst; useful for monitoring insider trend and potential follow-through selling.

03

What to watch

No 10b5-1 plan is indicated; traders may over-interpret intent—consider total insider activity over multiple filings and compare to prior sale/buy patterns.

Relevance 6/10Novelty 6/10Timing: Filed May 29, covering a May 28 sale

Background

The article is an SEC Form 4 insider transaction disclosure for XPO, Inc. (director Landry Allison).

Company-level read

Ticker impact

$XPONeutralMedium confidence
Context

Director Landry Allison filed an open-market sale of 2,400 XPO shares for ~$517K, updating insider ownership signals.

Expected impact

Low near-term impact; any move is likely sentiment-driven and limited unless follow-on selling accelerates.

Evidence & confidence

This is a single Form 4 sale with no 10b5-1 plan stated; however, insider sales are common and the filing alone rarely changes valuation without accompanying operational news.

Market effects

Minimal; insider transactions typically do not reset sector expectations.

None identifiable from the filing alone.

None identifiable from the filing alone.

Counterpoint

A director sale can be routine liquidity management rather than a bearish view, especially when not tied to a specific negative event.

Key entities

  • XPO, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Landry Allison

    Director who sold 2,400 shares on May 28 at ~$215.61/share.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$XPOHighAI 8/10

XPO stock reaffirmed at Buy by StoneX on strong LTL trends

StoneX reaffirmed a Buy rating and $240 price target on XPO, citing strong LTL trends and pricing discipline. XPO's Q2 2026 earnings beat estimates, with revenue up 13% YoY. Moody's upgraded XPO's rating to Ba1, while BofA maintained a Buy rating but lowered its target to $228. XPO's stock is up 36% YTD, with a market cap of $22.46B.

$XPOHigh

Moody’s upgrades XPO rating to Ba1 on margin gains

Moody's upgraded XPO's corporate family rating to Ba1 from Ba2, citing margin gains, stronger earnings, and improved credit metrics. The company's debt-to-EBITDA ratio fell to 2.8x, with revenue up 10% YoY. Moody's expects continued growth and deleveraging, with potential divestiture of XPO's European platform.

$XPOHigh

XPO upgraded by S&P, just one notch below investment-grade

S&P Global upgraded XPO's (NYSE: XPO) issuer credit rating to BB+ from BB, one notch below investment grade. The upgrade reflects improved trucking market fundamentals and better debt metrics, like a 35.7% FFO-to-debt ratio in Q2. XPO's senior secured debt remains investment-grade at BBB-. S&P's rating is now higher than Moody's, which kept XPO at Ba2 with a positive outlook.

$XPOMedAI 8/10

XPO Reports Second Quarter 2026 Results

XPO (NYSE: XPO) reported Q2 2026 results. Diluted EPS was $1.36 versus $0.89 in Q2 2025, and adjusted diluted EPS was $1.70 versus $1.05. Revenue rose to $2.36B from $2.08B. Operating income was $271M and net income $162M. Cash flow from operations was $308M.

$XPOMedAI 8/10

XPO Announces Financial Results for Second Quarter

XPO reported second-quarter 2026 results: revenue rose to $2.36B from $2.08B in 2025. Operating income increased to $271M, net income to $162M, and diluted EPS to $1.36. Adjusted diluted EPS was $1.70 and adjusted EBITDA $434M. North American LTL revenue grew to $1.43B and adjusted operating ratio improved to 79.9%.

$XPOMedAI 8/10

XPO records $162M in net income for Q2

XPO reported Q2 net income of $162M versus $106M in Q2 2025. Diluted EPS was $1.36 versus 89 cents. Revenue rose to $2.36B from $2.08B. Operating income increased to $271M from $198M. Adjusted net income was $201M and adjusted diluted EPS $1.70. Cash flow from ops was $308M; cash and equivalents were $298M.